http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-502345-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f07293d4b34d8372fb0775181fef9d23
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
filingDate 1968-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eb04a6a6884f56a4f5e9d31f10ab457
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4d4ba9d28bcf043303182e32d799f71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddcc67b736f989e84f7d8074479c90df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87d6f510de067ff4b71e0becffa5defc
publicationDate 1971-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CH-502345-A
titleOfInvention Process for the preparation of heterocyclically substituted hydrazino-imidazoline- (2)
abstract (A) Compounds - (I) A = a heteroaromatic ring system with 1-3 heteroatoms, opt. subst. by one or more (1-3C) alkyl, (1-3C)Alkyl, Cl, Br, or Ph opt. subst. by (1-3C)alkyl. - (B) Acid addn. salts of I. - Hypotensives, analgesics, anti-secretaries, vasoconstrictors, sedatives. Dose 0.05-100 mg. - 2-hydrazinopyridine (1.5 g.) and 2-methylmercaptoimidazoline-(2)-HI (3.26 g.), were refluxed 1 h. in AmOH, giving I (3.05 g.), m.p.202-3 deg.
priorityDate 1967-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20529324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21585056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411294351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13394118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451878892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421210999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454484741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448558341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13590464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135436526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31260

Total number of triples: 46.